ViaNautis
Cambridge
About ViaNautis
ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers such as the blood-brain barrier (BBB). PolyNaut, a versatile nano-engineered polymer technology that facilitates intracellular delivery, is used in collaboration with a number of partners. SomaServe is breaking new ground in the development of medications that can bypass various biological barriers and provide significant therapeutic benefits thanks to this technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $27.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2023)
- Website: vianautis.com
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/vianautis-94234 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.